Imidazopyridines
Medchemexpress LLC HY-112154 5mg Medchemexpress, CXCR7 modulator 2 CAS: Purity:>98%
Medchemexpress, HY-112154 5mg CXCR7 modulator 2 CAS: CXCR7 modulator 2 is a modulator of C-X-C Chemokine Receptor Type 7 ( CXCR7 ), with a K i of 13 nM. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC Dimethyl pyridine-2,6-dicarboxylate | 5453-67-8 | 195.17 | 100 G
Dimethyl pyridine-2,6-dicarboxylate is a biochemical reagent primarily used as a biological material or organic compound for life science-related research. It presents as a white to off-white solid, stable under recommended storage conditions. This product is intended for research use only.
- Used in laboratory chemicals and substance manufacturing
- Solid appearance
- Melting point 121-125°C
- Boiling point 321.7°C at 760 mmHg
![eMolecules 2001563-56-8 | 6-BROMO-3-FLUOROIMIDAZO[1,2-A]PYRIDINE | MFCD30829494 | 1g](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502198705.JPG-250.jpg)
eMolecules 2001563-56-8 | 6-BROMO-3-FLUOROIMIDAZO[1,2-A]PYRIDINE | MFCD30829494 | 1g
Ambeed | 1-Boc-5-fluoroindole-2-boronic Acid | 250mg | 721953864 | A319244 | 352359-23-0 | MFCD04114581 | 279.070 | C13H15BFNO4
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
![eMolecules 1092351-65-9 | 5-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid methyl ester | Combi-Blocks, Inc. | MFCD11109379 | 255.071 | C9H7BrN2O2 | 98.000 | COC(=O)c1cn2c(Br)cccc2n1 | 1g | 603154079](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502189595.JPG-250.jpg)
eMolecules 1092351-65-9 | 5-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid methyl ester | Combi-Blocks, Inc. | MFCD11109379 | 255.071 | C9H7BrN2O2 | 98.000 | COC(=O)c1cn2c(Br)cccc2n1 | 1g | 603154079
5-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid methyl ester | Combi-Blocks, Inc. | 1092351-65-9 | MFCD11109379 | 255.071 | C9H7BrN2O2 | 98.000 | COC(=O)c1cn2c(Br)cccc2n1 | 1g | 603154079
Medchemexpress LLC Cxcr7 modulator 1 | 2231812-31-8 | 99.5% | 914.07 | C48H57F2N7O7S | 50 MG
CXCR7 modulator 1 is a potent, orally bioavailable peptoid-hybrid modulator of the chemokine receptor CXCR7 with an in vitro Ki of 9 nM. It is supplied for preclinical biochemical and pharmacological research into CXCR7 signaling and ligand-receptor interactions.
- Potent CXCR7 affinity (Ki = 9 nM)
- Orally bioavailable chemical scaffold suitable for in vivo dosing studies
- High reported purity for reliable experimental results
- Supplied as a solid suitable for formulation and analytical work
- Available in multiple small research sizes for dose-ranging studies
![eMolecules 1332529-24-4 | (2-Imidazo[2,1-b][1,3]thiazol-6-yl-1-methylethyl)amine dihydrochloride | Combi-Blocks | MFCD18071257 | 254.170 | C8H13Cl2N3S | 95.000 | Cl.Cl.CC(N)Cc1cn2ccsc2n1 | 10g | 401041668](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502193012.JPG-250.jpg)
eMolecules 1332529-24-4 | (2-Imidazo[2,1-b][1,3]thiazol-6-yl-1-methylethyl)amine dihydrochloride | Combi-Blocks | MFCD18071257 | 254.170 | C8H13Cl2N3S | 95.000 | Cl.Cl.CC(N)Cc1cn2ccsc2n1 | 10g | 401041668
(2-Imidazo[2,1-b][1,3]thiazol-6-yl-1-methylethyl)amine dihydrochloride | Combi-Blocks | 1332529-24-4 | MFCD18071257 | 254.170 | C8H13Cl2N3S | 95.000 | Cl.Cl.CC(N)Cc1cn2ccsc2n1 | 10g | 401041668
![Medchemexpress LLC 4-Oxazolecarboxamide, N-[6-[(2-methoxyethyl)methylamino]-3-pyridinyl]-2-phenyl-5-(trifluorom | 939375-07-2 | 99.9% | 420.39 | 100 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000393984.png-250.jpg)
Medchemexpress LLC 4-Oxazolecarboxamide, N-[6-[(2-methoxyethyl)methylamino]-3-pyridinyl]-2-phenyl-5-(trifluorom | 939375-07-2 | 99.9% | 420.39 | 100 MG
DGAT1-IN-3 is a potent, selective, and orally bioavailable inhibitor of DGAT-1. It can be used for research on obesity, dyslipidemia, and metabolic syndrome.
- Potent, selective, and orally bioavailable inhibitor of DGAT-1.
- Inhibits human DGAT-1 with an IC50 of 38 nM.
- Inhibits rat DGAT-1 with an IC50 of 120 nM.
- Supports research into obesity.
- Supports research into dyslipidemia.
- Supports research into metabolic syndrome.
- Reduces cumulative body weight gain in DIO rats.
- Reduces weight gain and plasma triglycerides.
- Improves lipid profiles.
![Accela Chembio Inc Imidazo[1 | 2-a]pyridine-2-carboxylic Acid | 5g | 64951-08-2 | MFCD03419462 | 97+% | Shelf Life: 1260 Days | Light Sensitive](https://assets.fishersci.com/TFS-Assets/CCG/product-images/VN00116475-SY004051-5G.PNG-250.jpg)
Accela Chembio Inc Imidazo[1 | 2-a]pyridine-2-carboxylic Acid | 5g | 64951-08-2 | MFCD03419462 | 97+% | Shelf Life: 1260 Days | Light Sensitive
Imidazo[1 | 2-a]pyridine-2-carboxylic Acid | 5g | 64951-08-2 | MFCD03419462 | 97+% | Shelf Life: 1260 Days | Light Sensitive
Medchemexpress LLC (E)-5-((8-methoxy-2-methylquinolin-4-yl)amino)-N'-(4-(methylthio)benzylidene)-1H-indole-2-carbohydr | 2469975-55-9 | MFCD34167507 | 98.6% | 495.60 g/mol | C28H25N5O2S | 5 MG
Nur77 modulator 1 is a small-molecule ligand that binds the nuclear receptor Nur77 (KD = 3.58 μM). It up-regulates Nur77 expression, alters subcellular localization, induces Nur77-dependent endoplasmic reticulum stress and autophagy, and can lead to apoptosis; reported anti-hepatoma activity. For research use only.
- Binds Nur77 with a KD of 3.58 μM.
- Up-regulates Nur77 expression and alters subcellular localization.
- Induces ER stress and autophagy, leading to apoptosis.
- Reported anti-hepatoma activity in preclinical studies.
- High purity solid suitable for in vitro assays; soluble in DMSO.
- Available in multiple pack sizes for research workflows.